The revector program aims to develop methods to use human skin microbiomes to modulate chemical production in order to avoid mosquito attraction and feeding and reduce the threat of mosquito-borne…
Ended Definitive Contract Awarded Last action
- Contract number
- HR001120C0073
- Awardee
-
Ginkgo Bioworks, Inc. UEI ZRHJUJQSBRA4
- Awarding agency
-
Defense Advanced Research Projects Agency
Department of Defense
- Obligated
- $5,886,277
Award facts
- Opportunity
-
- ReVector Pre-Solicitation · HR001119S0056 · Posted May 14, 2019
- Award Notice for BTO ReVector Program Award Notice · Posted Oct 22, 2020
- Contract value 40% obligated
-
- $5,886,277.00 Current, with exercised options
- $14,605,403.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Basic Research
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Boston, MA 02210, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$105,271 | |
| Change Order | $0 | |
| Funding Only Action | $671,671 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $926,000 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $1,221,823 | |
| Original award | $3,172,054 |
About this award
This is a $14,605,403.00 cost-plus-fixed-fee definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Ginkgo Bioworks, Inc., a Boston-based biotechnology company. The contract is part of DARPA's ReVector program, which aims to develop methods to use human skin microbiomes to modulate chemical production in order to avoid mosquito attraction and feeding, thereby reducing the threat of mosquito-borne disease to U.S. military personnel.
The original solicitation, with no set-aside designation, was for proposals to identify microbiome-based metabolites that attract mosquitoes, design interventions to lessen attraction and feeding, and establish reliable and safe microbiome manipulation techniques. Multiple awards were anticipated over multiple performance periods to conduct in vitro and animal model studies. Ginkgo Bioworks, with its expertise in cellular engineering, DNA sequencing, and advanced biological manufacturing, was selected to deliver these critical capabilities to DARPA in support of warfighter health and readiness.
Description
The revector program aims to develop methods to use human skin microbiomes to modulate chemical production in order to avoid mosquito attraction and feeding and reduce the threat of mosquito-borne disease to warfighters.
Quick answers
Who was awarded contract HR001120C0073?
HR001120C0073 was awarded to Ginkgo Bioworks, Inc. by Defense Advanced Research Projects Agency (Department of Defense) on September 16, 2020.
How much is contract HR001120C0073 worth?
The government has obligated $5,886,277 on HR001120C0073. Its potential value, with all options, is $14,605,403.
Was contract HR001120C0073 competed?
The extent of competition for HR001120C0073 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award